Antipsychotic drugs (neuroleptics, major tranquillizers) are frequently prescribed for the relief of anxiety symptoms. A recent survey of a representative sample of psychiatrists found that these drugs are often given to patients who are not suffering from psychotic disorders, a practice that also appears to be common among general practitioners. Many authors have commented on the value of antipsychotics in relieving anxiety symptoms, both in the short and long term, as an alternative to benzodiazepines (with their associated risk of possible tolerance and dependence), although few recent papers recommend their use in this respect. This paper summarizes the evidence from treatment studies of antipsychotic drugs in patients with generalized anxiety disorder (GAD), and compares this with the advice given in major psychiatric textbooks. Most of the studies identified on the use of antipsychotic drugs in GADs appear to have major methodological flaws, and no study has considered the benefit/risk ratio carefully.
Baldwin D.S., Thomas S.C. (1997) 'There's a lot of it about': mixed anxiety and depression in primary care. Prim Care Psychiat3: in press
2.
Bandelow B., Rothemeyer M., Sievert K., Hajak G., Ruthe E. (1996) Panic disorder—acceptance of the diagnostic entity and treatment modalities preferred by German health professionals. Eur Psychiat11: 298-305
3.
Bjerrum H., Allerup P., Thundeborg K., Jakobsen K., Bech P. ( 1992) Treatment of generalised anxiety disorder: comparison of a new beta-blocking drug [CGP 361A], low dose neuroleptic [flupenthixol], and placebo. Pharmacopsychiatry25: 229-232
4.
Blazer D., Hughes D., George L.K. (1987) Stressful life events and the onset of generalised anxiety syndrome. Am J Psychiat144: 1178-1183
5.
Blazer D.G., Hughes D., George L.K., Swartz M., Boyer R. (1991) Generalised anxiety disorder. In Robins L, Regier DA (eds), Psychiatric disorder in America. Free Press , New York, pp.180-203
6.
Brown C., Schulberg H., Madonia M., Shear M.K., Houck P. (1996) Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiat153:1293-1300
7.
Budde G. (1992) Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: a multi-center trial in general practice. Prog in Neuropsychopharmac Biol Psychiat16: 677-689
8.
Cowen PJ (1997) Pharmacotherapy for anxiety disorders: drugs available . Adv Psychiat Treat3: 66-71
9.
Damsbo N., Lassen T., Haltho S. (1986) Flupenthixol [Fluanxol] or diazepam in the treatment of certain psychosomatic conditions. Ugeskr Laeger149:12-16 (in Danish)
10.
Fynboe C., Christensen N., Halberg T., Hansen E.A., Holm P., Knudsen J.P., Lindhardt J., Maul B., Musaeus Ch, Nielsen M.T., Schaumburg E. (1981) Bromazepam and chlorprothixene in acute psychoneurotic anxiety: a randomized double-blind comparison in general practice concerning the effect and risk of treatment resumption. Curr Therap Res30: 1014-1023
11.
Garrard J., Chen V., Dowd B. ( 1995) The impact of the 1987 Federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Pub Hlth85: 771-776
12.
Gelder M., Gath D., Mayou R., Cowen P. (1996) Oxford textbook of psychiatry, 3rd edn. Oxford University Press, Oxford
13.
Hoehn-Saric R., McLeod DR, Zimmerli WD (1988) Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiat49: 293-301
14.
Johnson Daw (1979) A double-blind comparison of flupenthixol, nortriptyline and diazepam in neurotic depression. Acta Psychiat Scand.59:1-8
15.
Kahn R.J., McNair D.M., Lipman R.S., Covi L., Rickels K., Downing R., Fisher S., Frankenthaler L.M. (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in outpatients. Archs Gen Psychiat43: 79-85
16.
Kammen D.P., Marder S.R. (1995) In Kaplan H I, Sadock B J (eds), 6th edn. Comprehensive textbook of psychiatry. Williams & Wilkins , Baltimore, MD, pp. 1987-2010
17.
Kappler J., Menges C., Ferbert A., Ebel H. ( 1994) Severe 'late' dystonia after neuroleptic anxiolysis with fluspirilene. Nervenarzt65(1): 66-68
18.
Kiessler RC, McGonagle KA, Zhao S., Nelson CB, Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. (1994) Life-time and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archs Gen Psychiat51: 8-19
19.
King D.J. (1995) Seminars in clinical psychopharmacology. Royal College of Psychiatrists, London
20.
Kragh-Sorenson P., Holm P., Fynboe C., Schaumburg E., Anderson B., Bech P., Pichard J. (1990) Bromazepam in generalised anxiety. Randomised, multi-practice comparisons with both chlorprothixene and placebo. Psychopharmacology100: 383-386
21.
Liebowitz M.R., Hollander E., Scheier F. (1990) Anxiety and depression : discrete diagnostic entities ? J Clin Psychopharmac10 (suppl.13): 61S-66S
22.
Lofft J., Demars J. (1974) A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis. Dis Nerv Syst September: 409-415
23.
Lohmann T., Ebel H., Ferbert A., Sass H. ( 1995) Tardive dystonias induced by very short-term therapy with low dose neuroleptics. Neurol Psychiat Brain Res3: 189-192
24.
Loudon J.B. (1993) In Kendell R E, Zealley A K (eds), Companion to psychiatric studies, 5th edn. Churchill Livingstone , Edinburgh, pp. 817-847
25.
Mannuzza S., Fryer A.J., Martin LY et al. (1989) Reliability of anxiety assessment. I. Diagnostic agreement. Archs Gen Psychiat46: 1093-1101
26.
Mendels J., Krajewski T.F., Huffer V., Taylor R.J., Secunda S., Schless A., Sebastian JA, Semchyshyn G., Durr M., Melmed AS, Whyte A. (1986) Effective short term treatment of generalised anxiety disorder with trifluoperazine. J Clin Psychiat47:170-174
27.
Mirabi M., Mathew R., Claghorn J. (1978) When is a neuroleptic appropriate in psychoneurosis ? Curr Ther Res23: 101-105
28.
Nutt D. ( 1997) Management of patients with depression associated with anxiety symptoms. J Clin Psychiat58 (Suppl. 8): 11-16
29.
Philipp M. (1995) Pharmacotherapy of anxiety disorders. Z Arztl Fortbild89:147-150 (in German)
30.
Prien R F, Robinson D S (eds) (1994) Clinical evaluation of psychotropic drugs: principles and guidelines. Raven Press, New York
31.
Priest RG, Montgomery SA (1988) Benzodiazepines and dependence : a College statement . Psychiat Bull12: 107-107
32.
Rickels K., Schweizer E. (1990) The clinical course and long-term management of generalised anxiety disorder. J Clin Psychopharmac10: 101S-110S
33.
Rickels K., Downing RW, Case W.G. et al. (1985) Six-week trial with diazepam: some clinical observations. J Clin Psychiat46: 470-474
34.
Rickels K., Amsterdam J., Clary C., Puzzoli G., Schweizer E. (1991) Buspirone in major depression: a controlled study . J Clin Psychiat52: 34-38
35.
Rickels K., Downing R., Schweizer E., Hassman H. (1993) Antidepressants for the treatment of generalized anxiety disorders: a placebo-controlled comparison of imipramine, trazodon and diazepam. Archs Gen Psychiat50: 884-895
36.
Rickels K., Noyes R., Jr, Robinson D.S., Schweizer E., Uhlenhuth EH (1994) Evaluating drug treatments of generalized anxiety disorder and adjustment disorders with anxious mood. In Prien R F, Robinson D S (eds), Clinical evaluation of psychotropic drugs: principles and guidelines . Raven Press, New York, pp. 373-409
37.
Royal College of Psychiatrists (1997) Benzodiazepines: risks, benefits or dependence, a re-evaluation. Council Report CR59. Royal College of Psychiatrists, London
38.
Sartorius N., Ustun T.B., Costa E., Silva L.A. et al. (1993) An international study of psychological problems in primary care. Arch Gen Psychiat50: 819-824
39.
Sartorius N., Ustun T.B., Lecrubier Y., Wittchen H-U. (1996) Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health cares. Br J Psychiat168 (Suppl. 30): 38-41
40.
Silberman E.K. (1994) Pharmacotherapy of anxiety disorders. In Wolman B B, Stricker G (eds), Anxiety and related disorders, a handbook. John Wiley Interscience, NewYork, pp. 318-339
41.
Thompson C. (1994) Consensus statement on the use of high-dose antipsychotic medication. Royal College of Psychiatrists. Br J Psychiat164: 448-458
42.
Ustun T B, Sartorius N (eds) (1995) Mental illnesses in general health care. An international study. John Wiley, Chichester
43.
Weissman M.M. (1990) Epidemiology of panic disorder and agoraphobia . Psychiat Med8: 3-13
44.
Wittchen H.M., Essau CA (1993) Epidemiology of panic disorder: progress and unresolved issues. J Psychiat Res27 (Supp.): 47-68
45.
Wurthmann C., Klieser E., Lehmann E., Pester U. (1995) Test therapy in the treatment of generalised anxiety disorders with low dose fluspirilene. Prog Neuropsychopharmac Biol Psychiat19: 1049-1060
